For Clinics

B2B resources and operational guidance for ketamine and psychedelic clinic owners.

Before a Buyer Calls: Getting Your Ketamine Clinic Ready for Acquisition

The first call rarely announces itself as an offer. It sounds like a compliment, someone building a platform in your

Read More

How to Get Your Ketamine Clinic Cited by ChatGPT, Perplexity, and Gemini

Patients are asking AI tools for ketamine clinic recommendations — and most clinics are invisible. Here are the 6 ranking

Read More

MAPS-Funded MDMA Therapy for PTSD Is Back at the FDA, Without a New Phase 3 Trial

MDMA assisted therapy for PTSD appears to be back in front of the FDA. Psychedelic Alpha reported on August 9

Read More

The FDA Just Showed Ketamine Clinics Exactly How a Crackdown Starts. Almost Nobody Noticed

The FDA's crackdown on compounded GLP-1 marketing is a preview for ketamine clinics. Your website copy may be your biggest

Read More

FDA Called Two Sentences on a Ketamine Booth Extremely Concerning

FDA cited Alar Pharmaceuticals over claims for an investigational ketamine product. The flagged phrases show up in a lot of

Read More

Review Finds Evidence for Ketamine Assisted Psychotherapy Remains Limited

Ketamine clinics often pair medication with therapy, preparation, or integration. A new review asks whether psychotherapy adds measurable benefit for

Read More

How Ketamine Clinics Can Improve Google Maps Visibility in 2026

A healthcare-specific Google Maps playbook for ketamine clinics — GBP, citations, reviews, and the 5 generic SEO tactics to skip.

Read More

An Oral LSD Tablet Has Now Cleared Phase 3 Twice This Year. Here Is What Comes Next

An oral LSD tablet has now cleared phase 3 twice in a single year. Definium Therapeutics reported that DT120 ODT

Read More

The Simple Website Detail That Makes Your Ketamine Clinic Look More Trustworthy

We see tons of ketamine clinic websites. While a lot of them look great, one little mistake can be the

Read More

A Controlled Trial Finally Tested Ketamine in the Patients Clinics Screen Out

Bipolar patients are routinely screened out of ketamine treatment over mania risk. A midazolam-controlled trial in JAMA Psychiatry finally tested

Read More

Explore Psychedelic Therapy Regions